Health Minister Sajid Javid issued Serious Deficiency Protocols (SSPs) to restrict the distribution of products. This means that Oestrogel, Ovestin cream and Premique Low Dose will be available in limited quantities to each person to “smooth out” the distribution. The move is in response to concerns about longer prescription cycles putting pressure on the availability of certain HRT products. However, those who already have a prescription for supplies for more than three months will not be required to pay the additional charges for the treatment they cannot access, the Ministry of Health and Social Welfare (DHSC) has confirmed. Mr Javid said: “I want to reassure women that I have heard their concerns and I will not hesitate to take decisive action to ensure that they can access the HRT they need. “We will not leave any step in our national mission to boost HRT delivery – and this next step will ensure that women across the UK can have reliable access to this vital medicine and maintain this lifeline for millions who need it. “ Hormone therapy helps fight the symptoms of menopause, which include anxiety, joint pain, disturbed sleep and hot flashes. The health ministry said the SSPs would expire on July 29, with pharmacists expected to “use their professional judgment” to decide how to implement them. NHS figures suggest that prescriptions for HRT have more than doubled in the UK in the last five years. About 538,000 HRT prescriptions were issued in December, compared to 238,000 in January 2017, according to OpenPrescribing. Use the Chrome browser for a more accessible video player 2:15 Lack of HRT medicine Amid continuing shortages, the company behind the popular HRT Oestrogel treatment recently said it is well on its way to meeting growing demand. Read more: Hormone replacement therapy tsar to be appointed as drug shortages make women feel suicidal Besins Healthcare UK, which makes the gel, said that from June women will be able to take long-term prescriptions and that more people will be able to start HRT as they plan to increase supplies. Mr Javid announced on Thursday that he had appointed Madelaine McTernan, Taskforce’s general manager for COVID Vaccine, to lead a new HRT Task Force, which the government said would “apply the lessons learned from the vaccine of the coronavirus “. Ms McTernan said: “This is a step in the right direction to address the supply problems women face in accessing HRT and ensuring a consistent, reliable supply.”


title: “Hrt Products Are Limited To A Three Month Supply To Smooth Distribution In The Uk Amid Shortages Uk News Klmat” ShowToc: true date: “2022-11-22” author: “Debra Tucker”


Health Minister Sajid Javid issued Serious Deficiency Protocols (SSPs) to restrict the distribution of products. This means that Oestrogel, Ovestin cream and Premique Low Dose will be available in limited quantities to each person to “smooth out” the distribution. The move is in response to concerns about longer prescription cycles putting pressure on the availability of certain HRT products. However, those who already have a prescription for supplies for more than three months will not be required to pay the additional charges for the treatment they cannot access, the Ministry of Health and Social Welfare (DHSC) has confirmed. Mr Javid said: “I want to reassure women that I have heard their concerns and I will not hesitate to take decisive action to ensure that they can access the HRT they need. “We will not leave any step in our national mission to boost HRT delivery – and this next step will ensure that women across the UK can have reliable access to this vital medicine and maintain this lifeline for millions who need it. “ Hormone therapy helps fight the symptoms of menopause, which include anxiety, joint pain, disturbed sleep and hot flashes. The health ministry said the SSPs would expire on July 29, with pharmacists expected to “use their professional judgment” to decide how to implement them. NHS figures suggest that prescriptions for HRT have more than doubled in the UK in the last five years. About 538,000 HRT prescriptions were issued in December, compared to 238,000 in January 2017, according to OpenPrescribing. Use the Chrome browser for a more accessible video player 2:15 Lack of HRT medicine Amid continuing shortages, the company behind the popular HRT Oestrogel treatment recently said it is well on its way to meeting growing demand. Read more: Hormone replacement therapy tsar to be appointed as drug shortages make women feel suicidal Besins Healthcare UK, which makes the gel, said that from June women will be able to take long-term prescriptions and that more people will be able to start HRT as they plan to increase supplies. Mr Javid announced on Thursday that he had appointed Madelaine McTernan, Taskforce’s general manager for COVID Vaccine, to lead a new HRT Task Force, which the government said would “apply the lessons learned from the vaccine of the coronavirus “. Ms McTernan said: “This is a step in the right direction to address the supply problems women face in accessing HRT and ensuring a consistent, reliable supply.”